Neurocrine Biosciences (NBIX) Misses Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $174.26 +3.87%
EPS Growth %: -4.2%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
CRMT, More
EPS Growth %: -4.2%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.40), $0.15 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
- Isabella Bank added to Russell 2000 index after Nasdaq listing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
